Rallybio Statistics
Total Valuation
Rallybio has a market cap or net worth of $12.98 million. The enterprise value is -$41.40 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Rallybio has 41.61 million shares outstanding. The number of shares has increased by 9.78% in one year.
| Current Share Class | 41.61M |
| Shares Outstanding | 41.61M |
| Shares Change (YoY) | +9.78% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 4.16% |
| Owned by Institutions (%) | 28.39% |
| Float | 19.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.38 |
| Forward PS | n/a |
| PB Ratio | 0.24 |
| P/TBV Ratio | 0.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.68, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.68 |
| Quick Ratio | 13.94 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.28% and return on invested capital (ROIC) is -43.83%.
| Return on Equity (ROE) | -67.28% |
| Return on Assets (ROA) | -40.02% |
| Return on Invested Capital (ROIC) | -43.83% |
| Return on Capital Employed (ROCE) | -93.17% |
| Revenue Per Employee | $33,920 |
| Profits Per Employee | -$1.93M |
| Employee Count | 25 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.64% in the last 52 weeks. The beta is -1.24, so Rallybio's price volatility has been lower than the market average.
| Beta (5Y) | -1.24 |
| 52-Week Price Change | -78.64% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.77 |
| Relative Strength Index (RSI) | 45.11 |
| Average Volume (20 Days) | 300,611 |
Short Selling Information
The latest short interest is 318,870, so 0.77% of the outstanding shares have been sold short.
| Short Interest | 318,870 |
| Short Previous Month | 356,942 |
| Short % of Shares Out | 0.77% |
| Short % of Float | 1.62% |
| Short Ratio (days to cover) | 3.75 |
Income Statement
In the last 12 months, Rallybio had revenue of $848,000 and -$48.19 million in losses. Loss per share was -$1.08.
| Revenue | 848,000 |
| Gross Profit | -38.66M |
| Operating Income | -50.38M |
| Pretax Income | -73.88M |
| Net Income | -48.19M |
| EBITDA | -50.26M |
| EBIT | -50.38M |
| Loss Per Share | -$1.08 |
Full Income StatementBalance Sheet
The company has $54.50 million in cash and $116,000 in debt, giving a net cash position of $54.38 million or $1.31 per share.
| Cash & Cash Equivalents | 54.50M |
| Total Debt | 116,000 |
| Net Cash | 54.38M |
| Net Cash Per Share | $1.31 |
| Equity (Book Value) | 54.07M |
| Book Value Per Share | 1.30 |
| Working Capital | 53.47M |
Full Balance SheetCash Flow
| Operating Cash Flow | -44.03M |
| Capital Expenditures | n/a |
| Free Cash Flow | -44.03M |
| FCF Per Share | -$1.06 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -5,940.92% |
| Pretax Margin | -5,682.19% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Rallybio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.78% |
| Shareholder Yield | -9.78% |
| Earnings Yield | -371.24% |
| FCF Yield | -339.23% |
Analyst Forecast
The average price target for Rallybio is $15.00, which is 4,709.23% higher than the current price. The consensus rating is "Hold".
| Price Target | $15.00 |
| Price Target Difference | 4,709.23% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 261.73% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Rallybio has an Altman Z-Score of -1.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.51 |
| Piotroski F-Score | 2 |